ENTA Live signals | Maximize Profits with Getagraph.com

BUY 93634 min ago

@ $13.07

Issued: 14 Feb 2024 @ 15:52

Return: 1.95%

Previous signal: Feb 14 - 09:30

Previous signal: Sell

Return: 4.73 %

Live Chart Being Loaded With Signals

Commentary (19 Apr 2024 @ 16:00):

Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases...

Stats
Today's Volume	136 813
Average Volume	238 067
Market Cap	281.80M
EPS	$0 ( 2024-02-07 )
Next earnings date	( $-1.330 ) 2024-05-06
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-2.03
ATR14	$0.0250 (0.19%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-06	Vance Terry	Buy	15 700	Stock Option (right to buy)
2024-03-06	Russell Lesley	Buy	15 700	Stock Option (right to buy)
2024-03-06	Peterson Kristine	Buy	15 700	Stock Option (right to buy)
2024-03-06	Hata Yujiro S	Buy	15 700	Stock Option (right to buy)
2024-03-06	Foletta Mark G	Buy	15 700	Stock Option (right to buy)

INSIDER POWER
70.06
Last 100 transactions
Buy: 1 263 491 \| Sell: 308 316

Volume Correlation

Long: 0.41 (neutral)

Short: -0.65 (weak negative)

Signal:(61.634) Neutral

Enanta Pharmaceuticals Correlation

10 Most Positive Correlations
MODV	0.977
CNXC	0.977
SBSI	0.975
NURO	0.975
HMST	0.974
TRVG	0.971
NWL	0.97
INDB	0.97
FSFG	0.97
TBNK	0.97

10 Most Negative Correlations
AGGR	-0.983
TBSA	-0.983
LEGA	-0.982
ACQR	-0.981
AHRN	-0.977
FRON	-0.976
LGAC	-0.976
FRSG	-0.975
HERA	-0.975
CFIV	-0.975

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Enanta Pharmaceuticals Correlation - Currency/Commodity

-0.60
( weak negative )

-0.86
( strong negative )

0.00
( neutral )

0.41
( neutral )

-0.82
( strong negative )

-0.74
( moderate negative )

Enanta Pharmaceuticals Financials

Annual	2023
Revenue:	$79.20M
Gross Profit:	$76.83M (97.01 %)
EPS:	$-6.38

Q4	2023
Revenue:	$18.93M
Gross Profit:	$18.26M (96.47 %)
EPS:	$-1.330

Q3	2023
Revenue:	$18.89M
Gross Profit:	$18.24M (96.55 %)
EPS:	$-1.860

Q2	2023
Revenue:	$17.80M
Gross Profit:	$17.26M (96.97 %)
EPS:	$-1.790

Financial Reports:

No articles found.

Enanta Pharmaceuticals

Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and license agreement with Abbott Laboratories to identify, develop, and commercialize HCV NS3 and NS3/4A protease inhibitor compounds, including paritaprevir and glecaprevir for the treatment of chronic hepatitis C virus. Enanta Pharmaceuticals, Inc. was founded in 1995 and is headquartered in Watertown, Massachusetts.